Oberland Capital Management

Oberland Capital is a private investment firm committed to funding innovation across the global healthcare industry. With approximately $3.2 billion in assets under management, Oberland Capital specializes in flexible investment structures for clinical-stage and commercial-stage companies, customized to meet the specific strategic and financial objectives of its partners. Oberland Capital employs a fundamental, research-driven approach coupled with quantitative methods to identify and invest in innovative technologies that have the potential to substantially improve the lives of patients worldwide. The firm focuses on investing in the pharmaceutical, biotechnology, medical device, and diagnostic industries.